组织蛋白修饰如何影响细胞辐射敏感性:药物向表观遗传调节器是克服放射电阻的有希望途径
Jiawei Song1, Lu Ye2, Wei-Qun Ding3
1Laboratory of Radiation Medicine, West China School of Basic Medical Sciences & Forensic Medicine, Sichuan University, Chengdu 610041, China.
Acta pharmaceutica Sinica. B
|January 1, 2026
概括
基斯修饰会影响癌细胞的辐射敏感性,影响放射治疗的成功. 针对这些修改提供了一个有希望的策略,以克服瘤的放射电阻和改善癌症治疗结果.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 放射治疗 (RT) 是一种主要的癌症治疗方法,但放射电阻限制了其有效性.
- 通过改变染色体结构,质子修饰在调节癌细胞辐射敏感性方面发挥着至关重要的作用.
- 异常的组织蛋白修饰与各种癌症和正常组织的辐射抵抗有关.
研究的目的:
- 为了全面总结异常的质子修饰和辐射抵抗之间的关系.
- 讨论组织蛋白修饰的调节机制及其对瘤辐射敏感性的影响.
- 探索针对激素修饰的治疗策略,以克服放射电阻.
主要方法:
- 文献综述和现有关于基因素修饰和放射敏感性的研究的综合.
- 分析涉及基因素修饰酶和蛋白质招募的调节机制.
- 讨论向激素修饰的治疗影响.
主要成果:
- 基质子修改通过调节染色质可访问性,显著影响瘤的辐射敏感性.
- 异常的基因组修饰与增加的放射电阻和潜在的辐射保护有关.
- 参与基因素修饰的酶调节影响放射敏感性的蛋白质的招募.
结论:
- 向激素修饰是一种有希望的治疗途径,可以提高放射治疗的疗效.
- 结合疗法包括质子修饰抑制剂和放射疗法可以改善临床结果.
- 需要进一步的研究,以充分阐明机制,并确定新的干预目标.
关键词:
癌症 癌症 癌症 癌症染色体重塑 染色体重塑 的方法组合疗法是一种联合疗法.表观遗传药物是一种表观遗传药物.基因组合物 基因组合物后翻译修改 (PTMs) 是指翻译后的修改.无线电阻可以抵抗辐射.辐射疗法 辐射疗法更多相关视频
05:39Author Spotlight: Radiotherapy and Clonogenic Assays for Advancing Cancer Research and Personalized Medicine
Published on: April 5, 2024
1.2K
11:24Measuring DNA Damage and Repair in Mouse Splenocytes After Chronic In Vivo Exposure to Very Low Doses of Beta- and Gamma-Radiation
Published on: July 3, 2015
11.5K
相关概念视频
Epigenetic Regulation
3.7K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.7K
Epigenetic Regulation
33.4K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.4K
Histone Modification
4.3K
4.3K
Histone Modification
15.8K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
15.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Spreading of Chromatin Modifications
9.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.2K
